Exelixis, Genomica Merger Passes End of Initial Offering Period | GenomeWeb
Home » Exelixis, Genomica Merger Passes End of Initial Offering Period

Exelixis, Genomica Merger Passes End of Initial Offering Period

Jan 02, 2002

SAN FRANCISCO, Jan. 2 - The proposed Genomica-Exelixis merger reached the close of its initial offering period for the exchange of its stock on Dec. 28 at Eastern Standard Time, Exelixis said on Wednesday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Sep 06, 2016

Danaher to Acquire Cepheid for Nearly $4 Billion in Cash

Dec 23, 2015

CombiMatrix Files for Preferred Stock, Warrants Offering

Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

Sep 06, 2016

Berry Genomics Seeks Public Listing in China Via Reverse Merger

Dec 31, 2015

NeoGenomics Completes Clarient Acquisition

Mar 23, 2016

Affymetrix Postpones Stockholder Meeting as Origin Ups Acquisition Offer; Board Backs Thermo Bid

The Scan

Choice Against Testing

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

Call for Gene Editing Oversight

The Japan Times says regulations are needed to oversee human genome-editing research.

This Week in PNAS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.